The response deadline has passed. Review the details for future reference or to track similar opportunities.
The Department of Defense is exercising options for the supply of Atovaquone-Proguanil through an existing contract with Golden State Medical Supply, Inc. The options extend the contract period through April 3, 2027.
Supply of Atovaquone-Proguanil pharmaceutical preparation.
Modification SPE2D224D0005 P00003 to exercise Option Year 2 effective April 4, 2026 through April 3, 2027. Modification SPE2D224D0005 P00002 is modified in accordance with DoD Class Deviation 2025-O0003. Modification SPE2D224D0005 P00001 to exercise Option Year 1 effective April 4, 2025 through April 3, 2026. Atovaquone National Contract SPE2D2-24-D-0005 Kyle Lewicki Alternative
Point of Contact Jason Wray to this opportunity. Modification P00003 SPE2D224D0005 Option Year 2.PDF Modification P00002 SPE2D224D0005.PDF Signed Option 1 Year P00001 SPE2D224D0005 Modification.pdf
Get matched to contracts like this daily
Free AI-powered contract matching for your business.